Search Results - "Pierce, GF"

Refine Results
  1. 1
  2. 2
  3. 3

    Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice by Scallan, Ciaran D., Jiang, Haiyan, Liu, Tongyao, Patarroyo-White, Susannah, Sommer, Jurg M., Zhou, Shangzhen, Couto, Linda B., Pierce, Glenn F.

    Published in Blood (01-03-2006)
    “…Long-term cures of hemophilia B have been achieved using AAV2 delivering the factor IX gene to the liver of adeno-associated virus (AAV)–naive hemophilic…”
    Get full text
    Journal Article
  4. 4

    Mutations on the External Surfaces of Adeno-Associated Virus Type 2 Capsids That Affect Transduction and Neutralization by Lochrie, Michael A, Tatsuno, Gwen P, Christie, Brian, McDonnell, Jennifer Wellman, Zhou, Shangzhen, Surosky, Richard, Pierce, Glenn F, Colosi, Peter

    Published in Journal of Virology (01-01-2006)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  5. 5

    Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs by Jiang, Haiyan, Lillicrap, David, Patarroyo-White, Susannah, Liu, Tongyao, Qian, Xiaobing, Scallan, Ciaran D., Powell, Sandra, Keller, Tracey, McMurray, Morag, Labelle, Andrea, Nagy, Dea, Vargas, Joseph A., Zhou, Shangzhen, Couto, Linda B., Pierce, Glenn F.

    Published in Blood (01-07-2006)
    “…Hemophilia A, a deficiency of functional coagulation factor VIII (FVIII), is treated via protein replacement therapy. Restoring 1% to 5% of normal blood FVIII…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation by Wright, J Fraser, Le, Tannie, Prado, Joseph, Bahr-Davidson, Jennifer, Smith, Peter H, Zhen, Zhu, Sommer, Jurg M, Pierce, Glenn F, Qu, Guang

    Published in Molecular therapy (01-07-2005)
    “…Aggregation of recombinant AAV2 results in reduced yield during purification and may have deleterious effects on vector transduction efficiency,…”
    Get full text
    Journal Article
  8. 8

    AAV2-mediated gene delivery to monkey putamen: Evaluation of an infusion device and delivery parameters by Sanftner, Laura M., Sommer, Jurg M., Suzuki, Brian M., Smith, Peter H., Vijay, Sharmila, Vargas, Joseph A., Forsayeth, John R., Cunningham, Janet, Bankiewicz, Krys S., Kao, Haihwa, Bernal, Jan, Pierce, Glenn F., Johnson, Kirk W.

    Published in Experimental neurology (01-08-2005)
    “…In this study, a modified infusion procedure and a novel infusion device designed for use in humans (Clinical Device B) were evaluated for delivery of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Adenovirus Encoding Human Platelet-Derived Growth Factor-B Delivered in Collagen Exhibits Safety, Biodistribution, and Immunogenicity Profiles Favorable for Clinical Use by Gu, Dan-ling, Nguyen, Thanh, Gonzalez, Ana Maria, Printz, Marie A, Pierce, Glenn F, Sosnowski, Barbara A, Phillips, M Laurie, Chandler, Lois A

    Published in Molecular therapy (01-05-2004)
    “…We have developed a therapeutic approach to wound repair involving immobilization of gene transfer vectors within biocompatible matrices (gene-activated…”
    Get full text
    Journal Article
  11. 11

    Delivery of FGF Genes to Wound Repair Cells Enhances Arteriogenesis and Myogenesis in Skeletal Muscle by Doukas, John, Blease, Kate, Craig, Darren, Ma, Chenglie, Chandler, Lois A., Sosnowski, Barbara A., Pierce, Glenn F.

    Published in Molecular therapy (01-05-2002)
    “…Tissue repair is driven by migratory macrophages and fibroblasts that infiltrate injury sites and secrete growth factors. We now report the enhancement of…”
    Get full text
    Journal Article
  12. 12

    Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP) by Liu, Tongyao, Scallan, Ciaran D, Broze, Jr, George J, Patarroyo-White, Susanna, Pierce, Glenn F, Johnson, Kirk W

    Published in Thrombosis and haemostasis (01-01-2006)
    “…Additional therapeutic options are needed for patients with bleeding disorders such as hemophilia A, hemophilia B, severe von Willebrand disease, and other…”
    Get more information
    Journal Article
  13. 13

    Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality by FARRELL, C. L, BREADY, J. V, HAVILL, A. M, LU, Z.-N, AUKERMAN, S. L, PIERCE, G. F, THOMASON, A, POTTEN, C. S, ULICH, T. R, LACEY, D. L, REX, K. L, CHEN, J. N, DIPALMA, C. R, WHITCOMB, K. L, SONGMEI YIN, HILL, D. C, WIEMANN, B, STARNES, C. O

    Published in Cancer research (Chicago, Ill.) (01-03-1998)
    “…Keratinocyte growth factor (KGF) stimulates the proliferation and differentiation of epithelial cells including those of the gastrointestinal tract. Although…”
    Get full text
    Journal Article
  14. 14

    Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage by Larocca, David, Kassner, Paul D., Witte, Alison, Ladner, Robert Charles, Pierce, Glenn F., Baird, Andrew

    Published in The FASEB journal (01-04-1999)
    “…We have genetically modified filamentous bacteriophage to deliver genes to mammalian cells. In previous studies we showed that noncovalently attached…”
    Get full text
    Journal Article
  15. 15

    Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds by Pierce, G F, Tarpley, J E, Tseng, J, Bready, J, Chang, D, Kenney, W C, Rudolph, R, Robson, M C, Vande Berg, J, Reid, P

    Published in The Journal of clinical investigation (01-09-1995)
    “…Some human chronic dermal wounds treated with recombinant platelet-derived growth factor-BB (rPDGF-BB) show increased healing coupled with fibroblast…”
    Get full text
    Journal Article
  16. 16

    Targeting bacteriophage to mammalian cell surface receptors for gene delivery by Larocca, D, Witte, A, Johnson, W, Pierce, G F, Baird, A

    Published in Human gene therapy (01-11-1998)
    “…Filamentous bacteriophages represent one of nature's most elegant ways of packaging and delivering DNA. In an effort to develop novel methods for ligand…”
    Get more information
    Journal Article
  17. 17

    Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo by ULICH, T R, YI, E. S, LONGMUIR, K, SONGMEI YIN, BILTZ, R, MORRIS, C. F, HOUSLEY, R. M, PIERCE, G. F

    Published in The Journal of clinical investigation (01-03-1994)
    “…Keratinocyte growth factor (KGF) administered as a single intratracheal injection causes a prominent dose-dependent proliferation of type II alveolar…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract by Housley, R M, Morris, C F, Boyle, W, Ring, B, Biltz, R, Tarpley, J E, Aukerman, S L, Devine, P L, Whitehead, R H, Pierce, G F

    Published in The Journal of clinical investigation (01-11-1994)
    “…Keratinocyte growth factor (KGF), a member of the fibroblast growth factor (FGF) family, was identified as a specific keratinocyte mitogen after isolation from…”
    Get full text
    Journal Article